Expression of coagulation factor IX (Christmas factor) in human hepatoma (HepG2) cell cultures after retroviral vector-mediated transfer.
Expression of coagulation factor IX (Christmas factor) in human hepatoma (HepG2) cell cultures after retroviral vector-mediated transfer.
复制标题
逆转录病毒载体介导的转移后人肝癌 (HepG2) 细胞培养物中凝血因子 IX(圣诞因子)的表达。
DOI:
10.1097/00043426-199305000-00007
复制
发表时间:
1993
期刊:
影响因子:
--
通讯作者:
Kohn,DB
中科院分区:
文献类型:
--
作者:
Gordon,EM;Tang,H;Salazar,RL;Kohn,DB
PurposeIn this study, we compared production of recombinant human factor IX by HepG 2 cells transduced with a cytomegalovirus (CMV) promoter-controlled factor IX vector to endogenous production of factor IX by non-transduced primary rat hepatocytes.Methods and ResultsNorthern analysis showed 2.8 kb transcripts corresponding to the known size of factor IX mRNA in primary hepatocyte preparations and vector factor IX transcripts of the expected sizes in transduced HepG 2 cell preparations. Factor IX produced by transduced HepG 2 cells was completely inhibited by a mono-specific antibody against human factor IX. Western analysis showed that recombinant factor IX migrated to the region of native plasma factor IX at 56 Kd. Production of biologically active factor IX by transduced HepG 2 cells was 20-fold greater than that by nontransduced primary hepatocytes.ConclusionThese data indicate that transduced HepG 2 cells transcribe, synthesize, and secrete authentic factor IX, and that these genetically engineered cells secrete significantly greater amounts of factor IX than do non-transduced primary hepatocytes. Studies are in progress to determine the effect of hepatocyte mitogens on production of factor IX in transduced HepG 2 cells and primary hepatocytes.